MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.

Saved in:
Bibliographic Details
Main Authors Deoliveira, Daniel B, Comstock, Jeanne Mary, Dong, Zheng Xin
Format Patent
LanguageEnglish
Published 03.06.2021
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
Bibliography:Application Number: US202117166756